Welcome to our dedicated page for Ianthus news (Ticker: ITHUF), a resource for investors and traders seeking the latest updates and insights on Ianthus stock.
iAnthus Capital Holdings, Inc. (ITHUF) is a vertically integrated cannabis company that owns, operates and partners with regulated cannabis operations across the United States. Its news flow combines operational updates from its GrowHealthy retail platform in Florida with regular financial reporting as a public company.
Recent company announcements highlight the expansion of GrowHealthy dispensaries in Florida communities such as Jacksonville, Palm Harbor, Tamarac, Fort Myers and St. Petersburg. These openings emphasize increased patient access to medical cannabis, a focus on whole-plant wellness and premium genetics, and store designs tailored to local communities. News releases describe product menus that include flower, vapes, concentrates and other formats, along with in-store features intended to enhance the patient experience.
Alongside retail expansion, iAnthus regularly reports quarterly and annual financial results. The company issues press releases summarizing revenue, gross profit, net income or loss and other key metrics, and discusses non-GAAP measures such as EBITDA and Adjusted EBITDA with reconciliations to GAAP figures. These releases are often accompanied by SEC filings, including Forms 10-Q, 10-K and 8-K.
Investors and observers following ITHUF news can use this page to review updates on dispensary openings, brand deployment across markets, financial performance and shareholder meeting outcomes. The news stream provides context on how iAnthus is executing its strategy of building premium cannabis brands through a network of cultivation, production and retail operations in the United States.
iAnthus Capital Holdings (CSE: IAN, OTCQB: ITHUF) reported its Q1 2024 financial results ending March 31, 2024. Revenue rose to $41.6 million, up 1.7% from Q4 2023 and 13.1% from Q1 2023. Gross profit increased to $17.2 million, with a gross margin of 41.4%. Net loss decreased to $14.0 million from $18.7 million in Q4 2023. Adjusted EBITDA grew to $3.2 million from $2.8 million in Q4 2023. The company continues to focus on operational efficiency and strategic growth in the U.S. regulated cannabis market. Detailed financials are available on the SEC and SEDAR+ websites.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.